June 21, 2016 -This premier awards program for the medtech industry announced the 2016 winners
Toronto, June 21, 2016: The Medical Design Excellence Awards (MDEA), the premier awards program for the medtech industry announced the 2016 winners on Tuesday, June 14th at a special ceremony at the MD&M East conference and exposition in
… Read MoreMay 19, 2016 -MolecuLight Exhibited at 26th European Wound Management Association (EWMA) Conference
MolecuLight exhibited for the very first time at the 26th Edition of the European Wound Management Association (EWMA) conference that took place in Bremen, German in May 11-13 2016. The conference was organized in cooperation with the Initiative Chronische Wunden
… Read MoreApril 20, 2016 -
MolecuLight Inc. exhibited at the 2016 SAWC Spring Conference that took place on April 13-17 at the Georgia World Congress Center in Atlanta, GA, USA.
There were over 150 Exhibitors from around the World.
Dr. Stephan Landis MD, FRCP(C) gave an oral poster presentation on Determining
… Read MoreMarch 15, 2016 -The new era of point-of-care testing
The March 2016 Issue of the Medical Post Magazine brings an article on ‘The new era of point-of-care testing. The latest devices are very different from those of the past. The big question is: will physicians use them?’ by Tristan Bronca.
“… Recently, Health
… Read MoreDecember 22, 2015 -MolecuLight participated in the Adopt-a-Senior 2015 program
This holiday season, MolecuLight participated in the Adopt-a-Senior 2015 program through LOFT Community Services. This charity provides attention to seniors who deal with loneliness and uncertainty at this special time of the year.
MolecuLight would like to wish everyone a happy and health
… Read MoreNovember 13, 2015 -MolecuLight Inc. launched the MolecuLight i:X at the CAWC Conference
MolecuLight Inc. launched the MolecuLight i:X at the CAWC (Canadian Association of Wound Care) Conference in Toronto, Canada (October 30th-November 1st 2015).
Clinicians across Canada attending the CAWC benefited from a close up view of the MolecuLight i:X imaging device during
… Read MoreNovember 1, 2015 -Dr. Ralph DaCosta’s eureka moment came in 2007 while doing a standard lab experiment
Dr. Ralph DaCosta, Molecular Imaging Scientist at Princess Margaret Cancer Centre and Techna Institute, University Health Network, has developed a first-of-its-kind device that enables clinicians to see and target bacteria in skin and chronic wounds… Read MoreOctober 20, 2015 -MolecuLight Inc. has been authorized to sell the MolecuLight i:X by Health Canada
TORONTO, Oct. 20, 2015 /CNW/ – MolecuLight ® Inc. has been authorized to sell the MolecuLight i:X by Health Canada. The approval will allow the company to begin selling the product throughout Canada. MolecuLight i:X is a novel, handheld fluorescence
… Read MoreOctober 6, 2015 -MolecuLight’s first time exhibiting at the SAWC
This was MolecuLight’s first time exhibiting at the SAWC (Society of Advanced Wound Care) Fall Conference (September 26-28 2015) to over 1000 wound care professionals.
Attendees learned about how MolecuLight’s handheld real-time imaging device allows for detection and visualization of clinically relevant bacteria
… Read More
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
©2025
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.